Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CyCol vs IV Cyclosporine PK and Safety in Healthy Volunteers
NCT02130414Phase 1Completed
- Sponsor
- Sigmoid Pharma
- Start
- Jul 2014
- Primary completion
- Jan 2015
- Modality
- Small Molecules
01
Overview
Phase 1, open-label trial of Cycol in ulcerative colitis (UC) (4 arms), sponsored by Sigmoid Pharma. Primary endpoints: Pharmacokinetic variables for cyclosporine (in whole blood) at Day 7 and Concentrations of cyclosporine and its metabolites in colonic mucosa at Day 7. Started Jul 2014; status: completed.
02
Drugs
Cycol
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT02130414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02130414.